Calendar

S M T W T F S
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
 
 
 
Add to calendar

Navigation

 

2010

Q: I am having more difficulty swallowing. Do you have any advice?

News Type: 
General

Sandra Lesher Stuban is an RN who was a 38-year old Lieutenant Colonel in the Army when she was diagnosed with ALS. She's the author of The Butcher's Daughter: The Story of an Army Nurse with ALS, in which she describes her journey openly and honestly.  Although she is completely paralyzed and uses a ventilator, she lives an active life as a writer, nursing leader and mother of a teenage son.

Q: I am having more difficulty swallowing. I think I will soon need a feeding tube. But I am nervous and feel like I am losing my fight against ALS.  Do you have any advice?

A: Sandra Lesher Stuban: A feeding tube, also known as a PEG (percutaneous endoscopic gastrostomy) or g-tube (gastric tube), is actually your way to win this one battle against ALS. ALS isn't defeating you, rather you are defying its paralyzing effects by using a simple comeback: the feeding tube. You can also look at a feeding tube as a pair of glasses. You could do without it but why make yourself miserable. Here are some general tips for living well with a feeding tube.

I am an advocate of keeping things simple. I know some people insist on pureeing the same food the family eats. However the same family mealtime dynamics can occur whatever the food choice. Therefore I recommend a liquid total nutrition meal such as Isocal, Nutren, Osmolite, and others. Plus, it's much easier for your loved one.

Caring for a feeding tube is very easy. Simply mix a few drops of liquid antibacterial soap with warm water then use a Q-tip to
clean the skin immediately beside the tube. Using tap water and Q-tips, remove the soapy fluid. And finally, dry the area with
 dry Q-tips. Do this every day. You can use apply gauze around the tube, but I suggest not using tape. The gauze will stay in
place if the split is on the bottom side of the tube.

If you have a length of tube lying on your abdomen, I find it convenient to loop the tube in a loose knot when not being used.
This keeps it from inadvertently being pulled during transfers.
     
As a precaution, it's best to take an acid reducer.  It's very easy for stomach acid to enter the tube tract. A feeding tube should be completely comfortable. If you feel burning or pain, this may be the cause.

External URL (if applicable): 
http://

Ask the Doc: Slowing ALS Progression

News Type: 
General

Ask the Doc: Q & A with Edward Kasarskis, MD, PhD 

Dr Kasarskis

Dr. Kasarskis

Edward Kasarskis, MD, PhD is Director of the University of Kentucky ALS Multidisciplinary Clinic at Cardinal Hill Rehabilitation Hospital in Lexington, Kentucky, professor in the Department of Neurology at the University of Kentucky, and Chief of Neurology at the VA Medical Center in Lexington KY. 

Q: How can I slow the progression of ALS? I hear there is one drug that can make some difference now and then others might be on the horizon?

Dr. Kasarskis:  

This is a question every person with ALS understandably asks. Today there is just one drug approved by the FDA to extend life for people with ALS, and that is riluzole (Rilutek®).  Here we are in the 21st century and it seems we have drugs for just about everything, so it is especially frustrating for patients and families to learn that we don’t have more pharmaceutical options when it comes to slowing the progression of ALS and extending survival.  There are many studies being conducted now and new drug approaches are being tested.

Riluzole was approved based on two survival studies from the 90’s which demonstrated that riluzole extended survival compared to placebo. Some people read or hear about the results described in riluzole’s package insert and get discouraged, asking "is that all there is?" After the initial results were submitted to the FDA for the approval of riluzole, further research showed a consistent survival benefit from taking riluzole.

In the future, we will probably be treating ALS with combination therapy in much the same way oncologists treat cancer, not relying on a single drug to cure the entire disease.  It is also important to realize that during the initial studies of riluzole, ALS physicians did not employ multi-disciplinary care as aggressively as we do now. Life can also be enhanced and even extended by getting multi-disciplinary care, which addresses the full range of issues facing a person with ALS. 

Many clinical drug trials are in the development phases or are underway.  For example, ceftriaxone, an antibiotic already approved by the FDA, is under study to determine if it (alone or in combination with riluzole) will slow the progression of the disease. (Ceftriaxone has other effects, in addition to being an antibiotic, but ALS is not infectious). This is a multicenter study at 60 sites in North America coordinated by Massachusetts General Hospital and supported by the National Institute of Neurological Disorders and Stroke (NINDS). For more information, visit http://clinicaltrials.gov/ct2/show/NCT00349622.

You should discuss participating in this or other clinical trials in your area.  As patients, we all stand on the shoulders of other patients before us who volunteered their time and their bodies to participate in a clinical drug study to prove that our blood pressure medication, or our antidepressant, or our drug for ALS is safe and effective. Clinical trials typically require regular testing and evaluation. They usually provide great psychological benefit, just from participating in something that can further our understanding of ALS and could directly help you and other ALS patients in the future.

External URL (if applicable): 
http://

Triangle Team Talent Show is a Big Hit

News Type: 
General

Cortney Mansfield, Activities and Volunteer Director at Brighton Gardens Assisted Living (Raleigh, NC) organized an ALS  Fundraiser Talent Show for residents on May 20, 2010 in honor of Diane Hardison.  Cortney invited residents and members of Diane’s family to participate as talent. Diane was the red carpet guest of honor and looked beautiful with her escort, Frank Hielema, Brighton Gardens Physical Therapist. Brighton Gardens Director, Karen Sherman served as emcee. The audience included residents, employees, and visiting families.

                    

The event started with Gretyl Kinsey’s video of Diane talking about living with ALS in her own words. Furniture was then moved aside and the floor opened up as a stage to accommodate 12 acts of live music, dance, and comedy routines. Diane’s mom , Hazel Sorrell ( age 94), did a comedy act; Diane’s  brother, Todd Sorrell joined Rocky Tutor as a vocal duo; her brother-in-law  and nephew , Tony McLamb and Zach McLamb played bluegrass music on bass and banjo;  her sister, Marilyn Kinsey  danced as Michael Jackson; and her niece, Gretyl Kinsey played the piano and sang. Other acts included residents and employees who line-danced, played the piano, and sang; a blind-folded chef act; and a resident’s granddaughter who played the piano. All performers received small trophies. Gretyl Kinsey won the grand prize for her very moving video. The talent show was enjoyed by all and raised over $500 for Diane’s Team in the 2010 Triangle Walk to Defeat ALS®.  
 

External URL (if applicable): 
http://

National ALS Registry Identifies ALS Cases Nationwide; Online Enrollment Coming Soon

News Type: 
Advocacy

The ALS Association has led the fight to establish a National ALS Registry, partnering with Congress and the Centers for Disease Control and Prevention to secure funding and to build the registry.   We are excited to report that the National ALS Registry is operational and has begun to identify cases of ALS across the country, including those who have lost their lives to the disease.  In fact, thousands of cases already have been identified through existing national databases, such as those for Medicare, Medicaid and the Department of Veterans Affairs.  

However, this is just the initial phase of the Registry.  The Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry (ATSDR) is now preparing to launch the National ALS Registry’s on-line web portal, which will enable all people with ALS across the country to self-enroll in the Registry.  The web portal is expected to “go live” later this year and will be available on the CDC’s ALS Registry website.  

The launch of the portal is the next phase in implementing the Registry.  Once fully implemented, the Registry will identify cases of ALS from across the country and collect data that is urgently needed to advance research into the causes of the disease and how it can be effectively treated.   Ultimately, the ALS Registry may become the single largest ALS research program ever created.  And it will mark the first time that data about ALS cases will be collected in such a comprehensive manner and on a nationwide scale.  

PALS Test ALS Registry Web Portal
At The ALS Association’s National ALS Advocacy Day and Public Policy Conference held in May, the ATSDR provided an update on the latest progress in implementing the Registry (Click here for the latest Registry Update).   The Agency also enlisted the help of several PALS attending the conference who tested a draft version of the online web portal.  PALS from Alabama, Maine, Mississippi, Nevada, and New Jersey provided feedback to the Agency on the ease of use of the portal, readability, layout and a number of other factors that will help to ensure that PALS and families can easily enroll in the Registry and that the Registry collects the vital information that will make it such a powerful research engine.

How Can PALS Enroll in the Registry?
To find out the latest information about the ALS Registry, including when PALS can begin to self-enroll, please sign-up to be an ALS Advocate via The Association’s website, here.   As an ALS Advocate, you will receive the most recent news about the ALS Registry.  And as the launch of the web portal approaches, The ALS Association also will provide detailed information about the Registry on our website, including answers to frequently asked questions, instructions on how PALS can enroll in the registry, flyers that can be shared at support groups, and other helpful information.     

We Still Need Your Help!
Although the Registry is almost fully operational, we still need your help!   That’s because Congressional funding is needed to continue enrollment in the Registry and to ensure the Registry provides vital information to researchers.   Thanks to your efforts, Congress already has provided $16 million over the past five years to design and launch the Registry.  But additional funding is needed and you can help by signing up to become an ALS Advocate.  By doing so, you will learn when your outreach to Congress can make the most difference.  And with your continued efforts, we can ensure that the Registry will fulfill the promise of helping to find the cause, treatment and cure for ALS.

 

External URL (if applicable): 
http://

There are Many Paths Toward a Cure




<!--[if gte mso 9]>

Normal
0




false
false
false

EN-US
X-NONE
X-NONE













MicrosoftInternetExplorer4













<![endif]--><!--[if gte mso 9]>
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267">
UnhideWhenUsed="false" QFormat="true" Name="Normal" />
UnhideWhenUsed="false" QFormat="true" Name="heading 1" />


















UnhideWhenUsed="false" QFormat="true" Name="Title" />

UnhideWhenUsed="false" QFormat="true" Name="Subtitle" />
UnhideWhenUsed="false" QFormat="true" Name="Strong" />
UnhideWhenUsed="false" QFormat="true" Name="Emphasis" />
UnhideWhenUsed="false" Name="Table Grid" />

UnhideWhenUsed="false" QFormat="true" Name="No Spacing" />
UnhideWhenUsed="false" Name="Light Shading" />
UnhideWhenUsed="false" Name="Light List" />
UnhideWhenUsed="false" Name="Light Grid" />
UnhideWhenUsed="false" Name="Medium Shading 1" />
UnhideWhenUsed="false" Name="Medium Shading 2" />
UnhideWhenUsed="false" Name="Medium List 1" />
UnhideWhenUsed="false" Name="Medium List 2" />
UnhideWhenUsed="false" Name="Medium Grid 1" />
UnhideWhenUsed="false" Name="Medium Grid 2" />
UnhideWhenUsed="false" Name="Medium Grid 3" />
UnhideWhenUsed="false" Name="Dark List" />
UnhideWhenUsed="false" Name="Colorful Shading" />
UnhideWhenUsed="false" Name="Colorful List" />
UnhideWhenUsed="false" Name="Colorful Grid" />
UnhideWhenUsed="false" Name="Light Shading Accent 1" />
UnhideWhenUsed="false" Name="Light List Accent 1" />
UnhideWhenUsed="false" Name="Light Grid Accent 1" />
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1" />
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1" />
UnhideWhenUsed="false" Name="Medium List 1 Accent 1" />

UnhideWhenUsed="false" QFormat="true" Name="List Paragraph" />
UnhideWhenUsed="false" QFormat="true" Name="Quote" />
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote" />
UnhideWhenUsed="false" Name="Medium List 2 Accent 1" />
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1" />
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1" />
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1" />
UnhideWhenUsed="false" Name="Dark List Accent 1" />
UnhideWhenUsed="false" Name="Colorful Shading Accent 1" />
UnhideWhenUsed="false" Name="Colorful List Accent 1" />
UnhideWhenUsed="false" Name="Colorful Grid Accent 1" />
UnhideWhenUsed="false" Name="Light Shading Accent 2" />
UnhideWhenUsed="false" Name="Light List Accent 2" />
UnhideWhenUsed="false" Name="Light Grid Accent 2" />
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2" />
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2" />
UnhideWhenUsed="false" Name="Medium List 1 Accent 2" />
UnhideWhenUsed="false" Name="Medium List 2 Accent 2" />
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2" />
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2" />
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2" />
UnhideWhenUsed="false" Name="Dark List Accent 2" />
UnhideWhenUsed="false" Name="Colorful Shading Accent 2" />
UnhideWhenUsed="false" Name="Colorful List Accent 2" />
UnhideWhenUsed="false" Name="Colorful Grid Accent 2" />
UnhideWhenUsed="false" Name="Light Shading Accent 3" />
UnhideWhenUsed="false" Name="Light List Accent 3" />
UnhideWhenUsed="false" Name="Light Grid Accent 3" />
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3" />
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3" />
UnhideWhenUsed="false" Name="Medium List 1 Accent 3" />
UnhideWhenUsed="false" Name="Medium List 2 Accent 3" />
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3" />
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3" />
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3" />
UnhideWhenUsed="false" Name="Dark List Accent 3" />
UnhideWhenUsed="false" Name="Colorful Shading Accent 3" />
UnhideWhenUsed="false" Name="Colorful List Accent 3" />
UnhideWhenUsed="false" Name="Colorful Grid Accent 3" />
UnhideWhenUsed="false" Name="Light Shading Accent 4" />
UnhideWhenUsed="false" Name="Light List Accent 4" />
UnhideWhenUsed="false" Name="Light Grid Accent 4" />
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4" />
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4" />
UnhideWhenUsed="false" Name="Medium List 1 Accent 4" />
UnhideWhenUsed="false" Name="Medium List 2 Accent 4" />
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4" />
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4" />
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4" />
UnhideWhenUsed="false" Name="Dark List Accent 4" />
UnhideWhenUsed="false" Name="Colorful Shading Accent 4" />
UnhideWhenUsed="false" Name="Colorful List Accent 4" />
UnhideWhenUsed="false" Name="Colorful Grid Accent 4" />
UnhideWhenUsed="false" Name="Light Shading Accent 5" />
UnhideWhenUsed="false" Name="Light List Accent 5" />
UnhideWhenUsed="false" Name="Light Grid Accent 5" />
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5" />
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5" />
UnhideWhenUsed="false" Name="Medium List 1 Accent 5" />
UnhideWhenUsed="false" Name="Medium List 2 Accent 5" />
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5" />
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5" />
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5" />
UnhideWhenUsed="false" Name="Dark List Accent 5" />
UnhideWhenUsed="false" Name="Colorful Shading Accent 5" />
UnhideWhenUsed="false" Name="Colorful List Accent 5" />
UnhideWhenUsed="false" Name="Colorful Grid Accent 5" />
UnhideWhenUsed="false" Name="Light Shading Accent 6" />
UnhideWhenUsed="false" Name="Light List Accent 6" />
UnhideWhenUsed="false" Name="Light Grid Accent 6" />
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6" />
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6" />
UnhideWhenUsed="false" Name="Medium List 1 Accent 6" />
UnhideWhenUsed="false" Name="Medium List 2 Accent 6" />
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6" />
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6" />
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6" />
UnhideWhenUsed="false" Name="Dark List Accent 6" />
UnhideWhenUsed="false" Name="Colorful Shading Accent 6" />
UnhideWhenUsed="false" Name="Colorful List Accent 6" />
UnhideWhenUsed="false" Name="Colorful Grid Accent 6" />
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis" />
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis" />
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference" />
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference" />
UnhideWhenUsed="false" QFormat="true" Name="Book Title" />



<![endif]-->

<!--[if gte mso 10]>

<![endif]--> It’s a new year and with that comes renewed hope for those living with ALS.  Now is a great opportunity to support The ALS Association Jim “Catfish” Hunter Chapter and fight against Lou Gehrig’s Disease.  Listed below are a few suggestions that I believe will help strengthen our partnership together and maintain our progress in 2010.


I know that you are doing everything you can to help create a world without ALS.  I hope these suggestions open new doors of possibilities for you.  We all share the common goal of a cure for Lou Gehrig’s Disease, and there are many paths to making that goal a reality. Thank you for your unwavering dedication.

Together for a treatment, cure and improved care,

Jerry Dawson
President and CEO <!--[if !supportLineBreakNewLine]-->

<!--[endif]-->

High School Senior's Tennis Tournament Raises Funds and Awareness

News Type: 
General

Over the summer, high school senior Macon Cornick’s father was diagnosed with ALS. With help from her mother Gina, she planned a tennis tournament to raise awareness and funds for The ALS Association - Jim "Catfish" Hunter Chapter.

 

External URL (if applicable): 
http://

New Brochure: The ALS Association Certified Centers

News Type: 
General

An exciting new brochure is now available; it’s all about our Certified Centers and the value of the multidisciplinary approach.

See and read the entire brochure at: http://catfishchapter.org/sites/default/files/catfishfiles/center_brochure.pdf

 

 

External URL (if applicable): 
http://

Ask the Doc: Q & A with Edward Kasarskis, MD, PhD - New AAN guidelines

News Type: 
General

 

Ask the Doc: Q & A with Edward Kasarskis, MD, PhD 

 
 

Edward Kasarskis, MD, PhD is Director of the University of Kentucky ALS Multidisciplinary Clinic at Cardinal Hill Rehabilitation Hospital in Lexington, Kentucky, professor in the Department of Neurology at the University of Kentucky, and Chief of Neurology at the VA Medical Center in Lexington KY. 

Q: I heard that the American Academy of Neurology (AAN) has just come out with new guidelines for the care of people with ALS. Will those guidelines change the care I'm getting now or what my doctor is doing for me?

 

External URL (if applicable): 
http://

ALS Association Commemorates 25th Anniversary

News Type: 
General

January, 2010 

logo_anniversaryALS Association Optimistic New Treatments and Cure
Will Be Found As Organization Commemorates Anniversary

By Gary Wosk, Staff Writer 

The ALS Association, marking its 25th anniversary in 2010 as a leader in the fight against ALS, more than ever, is optimistic that major discoveries will be made in the near future that will help people with this disease live longer, better quality lives and that some day there will be a cure.

The Association was created in 1985 when the California-based ALS Society of America merged with the New York-based National ALS Foundation.

Fri, 01/08/2010 - 5:10pm

Help the Chapter without Spending Money!

News Type: 
General

Raise money for the Chapter every time you search the web! iSearchiGive.com is a search engine powered by iGive.com,
the internet's first online shopping mall where a portion of each purchase is donated to your favorite cause. iGive is bringing you the best, easiest way to raise money when you search the web.

No hidden fees. No vague percentages. No limits. And donation checks are sent promptly to the Chapter every month.

External URL (if applicable): 
http://
Follow us on Twitter Connect with us on Facebook Keep up with us via RSS Visit our YouTube page   

The Catfish Blog

01/31/2012 - 11:35am
In response to Chapter growth, the Special Events Administrative...
01/20/2012 - 2:54pm
With a brand new year and January underway, perhaps a new year’s goal to...
12/24/2011 - 5:19pm
‘Twas the day after Memorial and a long one in Durham; Starting at eight...
12/19/2011 - 2:27pm
This month I’d like to continue to focus on the caregivers.  The holiday...
12/05/2011 - 10:03am
We could not culminate our “Thankful Series” without mentioning a very...
11/30/2011 - 10:32am
The day after Thanksgiving may be known to some people as Black Friday. ...
11/23/2011 - 3:20pm
Our walk committee members are groups of people, working in eight...
11/22/2011 - 1:08pm
One of the joys of being a special events coordinator is to witness and...
11/18/2011 - 2:38pm
This is to all the caregivers out there….  Who cares for you?  I...